We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » HHS Unveils Small Number of Planned Rules for FDA in Semiannual Agenda
HHS Unveils Small Number of Planned Rules for FDA in Semiannual Agenda
HHS has released its latest semiannual regulatory agenda with just four planned drug-related actions by the FDA — three proposed rules and one final rule.